{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:03:52Z","timestamp":1777579432054,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A6A1A03025124"],"award-info":[{"award-number":["2018R1A6A1A03025124"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.actatropica.2024.107501","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T19:57:05Z","timestamp":1734379025000},"page":"107501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Protective humoral immunity induced by virus-like particles expressing Toxoplasma gondii CST1 or MIC8"],"prefix":"10.1016","volume":"261","author":[{"given":"Jie","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi-Deok","family":"Eom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keon-Woong","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su In","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Ji","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Back","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Kyung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Shi","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2024.107501_bib0001","first-page":"1489","article-title":"Within-host parasite dynamics, emerging trade-off, and evolution of virulence with immune system","volume":"57","author":"Andr\u00e9","year":"2003","journal-title":"Evolution (N Y)"},{"key":"10.1016\/j.actatropica.2024.107501_bib0002","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01974-21","article-title":"Beware of mycoplasma anti-immunoglobulin strategies","volume":"12","author":"Arfi","year":"2021","journal-title":"MBio"},{"key":"10.1016\/j.actatropica.2024.107501_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.621997","article-title":"Vaccines in congenital toxoplasmosis: advances and perspectives","volume":"11","author":"Barros","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0004","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/104454903767650676","article-title":"Parasites and immune responses: memory illusion?","volume":"22","author":"Brake","year":"2003","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/vaccines11040733","article-title":"Nanoparticles as a delivery system of antigens for the development of an effective vaccine against Toxoplasma gondii","volume":"11","author":"Brito","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.actatropica.2024.107501_bib0006","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/vaccines9080920","article-title":"Influenza virus-like particle (VLP) vaccines expressing the SARS-CoV-2 S glycoprotein, S1, or S2 domains","volume":"9","author":"Chu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.actatropica.2024.107501_bib0007","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/vaccines9050413","article-title":"Advances in Toxoplasma gondii vaccines: current strategies and challenges for vaccine development","volume":"9","author":"Chu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.actatropica.2024.107501_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.702125","article-title":"Revisiting the mechanisms of immune evasion employed by human parasites","volume":"11","author":"Chulanetra","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0009","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pt.2020.09.006","article-title":"Serology for Toxoplasma in immunocompromised patients: still useful?","volume":"37","author":"Dupont","year":"2021","journal-title":"Trend. Parasitol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283928","article-title":"Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein","volume":"18","author":"Eom","year":"2023","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2024.107501_bib0011","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1080\/17435889.2024.2403333","article-title":"Heterologous immunization targeting the CST1 antigen confers better protection than ROP18 in mice","volume":"19","author":"Eom","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actatropica.2024.107501_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7774\/cevr.2019.8.1.4","article-title":"Rhoptry antigens as Toxoplasma gondii vaccine target","volume":"8","author":"Foroutan","year":"2019","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.actatropica.2024.107501_bib0013","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7774\/cevr.2018.7.2.93","article-title":"Recent progress in microneme-based vaccines development against Toxoplasma gondii","volume":"7","author":"Foroutan","year":"2018","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.actatropica.2024.107501_bib0014","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/vaccines11071218","article-title":"Application of Baculovirus Expression Vector System (BEVS) in vaccine development","volume":"11","author":"Hong","year":"2023","journal-title":"Vaccine. (Basel)"},{"key":"10.1016\/j.actatropica.2024.107501_bib0015","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1017\/S0950268818002947","article-title":"Human toxoplasmosis: a systematic review for genetic diversity of Toxoplasma gondii in clinical samples","volume":"147","author":"Hosseini","year":"2019","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.actatropica.2024.107501_bib0016","first-page":"8","article-title":"Evaluation on the immune response induced by DNA vaccine encoding MIC8 co-immunized with IL-12 genetic adjuvant against toxoplasma gondii infection","volume":"31","author":"Huan-ge","year":"2013","journal-title":"Chin. J. Parasitol. Parasit. Dis."},{"key":"10.1016\/j.actatropica.2024.107501_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110872","article-title":"Immune system roles in pathogenesis, prognosis, control, and treatment of Toxoplasma gondii infection","volume":"124","author":"Jafari","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0018","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/vaccines9050425","article-title":"Passive Immunity and Antibody Response Induced by Toxoplasma gondii VLP Immunization","volume":"9","author":"Kang","year":"2021","journal-title":"Vaccine. (Basel)"},{"key":"10.1016\/j.actatropica.2024.107501_bib0019","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/pharmaceutics11070342","article-title":"Influenza virus-like particles presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii infection","volume":"11","author":"Kang","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actatropica.2024.107501_bib0020","doi-asserted-by":"crossref","first-page":"e12716","DOI":"10.1111\/pim.12716","article-title":"Toxoplasma gondii virus-like particle vaccination alleviates inflammatory response in the brain upon T gondii infection","volume":"42","author":"Kang","year":"2020","journal-title":"Parasit. Immunol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102226","article-title":"Immune responses to Toxoplasma gondii","volume":"77","author":"Khan","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0022","article-title":"Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein","volume":"13","author":"Kim","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2024.107501_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104090","article-title":"Virus-like particle vaccine displaying Toxoplasma gondii apical membrane antigen 1 induces protection against T. gondii ME49 infection in mice","volume":"142","author":"Kim","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.actatropica.2024.107501_bib0024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.actatropica.2016.08.025","article-title":"Cross-protection induced by Toxoplasma gondii virus-like particle vaccine upon intraperitoneal route challenge","volume":"164","author":"Lee","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2024.107501_bib0025","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1016\/j.vaccine.2018.08.016","article-title":"Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection","volume":"36","author":"Lee","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2024.107501_bib0026","article-title":"Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2024.107501_bib0027","article-title":"Protective effect against toxoplasmosis in BALB\/C mice vaccinated with recombinant Toxoplasma gondii CDPK3, GRA35, and ROP46 protein cocktail vaccine","author":"Li","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2024.107501_bib0028","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/vaccines11050963","article-title":"Long-term cross immune response in mice following heterologous prime-boost COVID-19 vaccination with full-length spike mRNA and recombinant S1 protein","volume":"11","author":"Li","year":"2023","journal-title":"Vaccine. (Basel)"},{"key":"10.1016\/j.actatropica.2024.107501_bib0029","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00436-010-1742-0","article-title":"Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis","volume":"106","author":"Liu","year":"2010","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2024.107501_bib0030","doi-asserted-by":"crossref","first-page":"e63201","DOI":"10.1371\/journal.pone.0063201","article-title":"Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1","volume":"8","author":"Mendes","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2024.107501_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.607198","article-title":"Key limitations and new insights into the Toxoplasma gondii parasite stage switching for future vaccine development in human, livestock, and cats","volume":"10","author":"M\u00e9v\u00e9lec","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0032","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.pt.2020.08.005","article-title":"Toxoplasma gondii: an underestimated threat?","volume":"36","author":"Milne","year":"2020","journal-title":"Trend. Parasitol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0033","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.micpath.2018.11.003","article-title":"A systematic review of Toxoplasma gondii antigens to find the best vaccine candidates for immunization","volume":"126","author":"Rezaei","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.actatropica.2024.107501_bib0034","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.262796299","article-title":"Link between immune response and parasite synchronization in malaria","volume":"100","author":"Rouzine","year":"2003","journal-title":"Proceed. Natl. Acad. Sci."},{"key":"10.1016\/j.actatropica.2024.107501_bib0036","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpara.2020.11.001","article-title":"Control of human toxoplasmosis","volume":"51","author":"Smith","year":"2021","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0037","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/337999","article-title":"Host resistance in the brain against Toxoplasma gondii","volume":"185","author":"Suzuki","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2024.107501_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003823","article-title":"The Toxoplasma gondii cyst wall protein CST1 is critical for cyst wall integrity and promotes bradyzoite persistence","volume":"9","author":"Tomita","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.actatropica.2024.107501_bib0039","series-title":"Toxoplasma Gondii: Method. Protocol.","first-page":"99","article-title":"Assays for monitoring Toxoplasma gondii infectivity in the laboratory mouse","author":"Wang","year":"2020"},{"key":"10.1016\/j.actatropica.2024.107501_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.735191","article-title":"Mucosal administration of recombinant baculovirus displaying toxoplasma gondii ROP4 confers protection against t. gondii challenge infection in mice","volume":"11","author":"Yoon","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2024.107501_bib0041","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/vaccines10020152","article-title":"Orally administrated recombinant vaccinia virus displaying ROP4 induces protection against Toxoplasma gondii challenge infection","volume":"10","author":"Yoon","year":"2022","journal-title":"Vaccine. (Basel)"},{"key":"10.1016\/j.actatropica.2024.107501_bib0042","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/acsinfecdis.3c00411","article-title":"Protective humoral immune response induced by recombinant virus-like particle vaccine expressing leishmania donovani surface antigen","volume":"9","author":"Yoon","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.actatropica.2024.107501_bib0043","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.immuni.2021.07.015","article-title":"The unique biology of germinal center B cells","volume":"54","author":"Young","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.actatropica.2024.107501_bib0044","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41541-022-00563-0","article-title":"Toxoplasmosis vaccines: what we have and where to go?","volume":"7","author":"Zhang","year":"2022","journal-title":"npj Vaccine."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X24003851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X24003851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:58:52Z","timestamp":1777384732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X24003851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":43,"alternative-id":["S0001706X24003851"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2024.107501","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective humoral immunity induced by virus-like particles expressing Toxoplasma gondii CST1 or MIC8","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2024.107501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107501"}}